Adagio Medical Holdings (ADGM) Notes Payables (2023)

Adagio Medical Holdings (ADGM) reported Notes Payables of $36.4 million for Q4 2023.

Adagio Medical Holdings (ADGM) Notes Payables (2023) Analysis & Trends

Adagio Medical Holdings (ADGM) has 1 years of Notes Payables data on file, last reported at $36.4 million in Q4 2023.

  • Notes Payables for Q4 2023 came in at $36.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $36.4 million (changed N/A YoY), and the FY2023 annual result was $36.4 million, changed N/A from the prior year.
  • Notes Payables was little changed at $36.4 million in Q4 2023 per ADGM's latest filing.
  • Over five years, Notes Payables peaked at $36.4 million in Q4 2023 and troughed at $36.4 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Adagio Medical Holdings 15.88 Mn 2.97 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 36.43 Mn